Sinobioway Highlights of 2026 Mid-Year Performance
August 25, 2026 — 22:15 CST
This Data Is Locked!
This area is available only to Subscribers.
Sinobioway Pharmaceutical Group (Hong Kong Stock Exchange Code: 01801), a leading biopharmaceutical company focusing on innovative drugs in the fields of oncology, metabolism, cardiovascular, autoimmune,... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
